| 5LEZ |
|
date |
 |
| authors | |
| compound |
source |
| symmetry | |
|
crystal cell |
| length a |
length b |
length c |
angle alpha |
angle beta |
angle gamma |
|
|
|
|
|
|
|
| method | X-Ray Diffraction | resolution | |
| ligand | 1PE, 6V1, 6V9, 6VA, ACT, K, MG, OAS, YCM
| enzyme |
|
Gene Ontology |
| Chain | Function | Process | Component | | E, S |
|
|
|
| F, T |
|
|
|
| J, X |
|
|
|
| K, Y |
|
|
|
| M, a |
|
|
|
| O, A |
|
|
|
| P, B |
|
|
|
| Q, C |
|
|
|
| R, D |
|
|
|
| U, G |
| positive regulation of NF-ka... |
|
| W, I |
|
|
|
| Z, L |
|
|
|
| b, N, V, H |
|
|
|
|
| Primary reference | The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design., Schrader J, Henneberg F, Mata RA, Tittmann K, Schneider TR, Stark H, Bourenkov G, Chari A, Science. 2016 Aug 5;353(6299):594-8. doi: 10.1126/science.aaf8993. PMID:27493187 |